Stocks
Syneos Health, Inc.SYNH
NASDAQHealthcareBiotechnology$42.98+0.02%
Price as of · delayed, not real-time
A global contract research organization (CRO) and biopharmaceutical solutions provider, the company specializes in clinical trial management, commercialization, and consulting services. Its integrated approach to drug development and commercialization makes it a key player in the pharmaceutical and biotechnology sectors, attracting investor interest due to its role in accelerating drug approvals and market launches.
Market Cap: $4.5B52W Range: $22.89 – $52.23
Congressional Interest in Syneos Health, Inc. (SYNH)
4 members of Congress have disclosed 9 trades in Syneos Health, Inc. (SYNH), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 7 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
4
Buys
2
Sells
7
Who in Congress Is Trading SYNH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-01-31 | Daniel Goldman | sell | $1K – $15K |
| 2023-01-23 | Josh Gottheimer | sell | $1K – $15K |
| 2022-12-06 | Josh Gottheimer | sell | $1K – $15K |
| 2022-11-30 | Susie Lee | sell | $1K – $15K |
| 2022-01-04 | Josh Gottheimer | sell | $1K – $15K |
| 2021-09-24 | Susie Lee | buy | $1K – $15K |
| 2021-08-20 | Josh Gottheimer | sell | $1K – $15K |
| 2020-11-03 | Gilbert Cisneros | sell | $1K – $15K |
| 2019-08-15 | Gilbert Cisneros | buy | $1K – $15K |